Castle Biosciences CSTL Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Plus components not separately reported this period.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's total debt?
- Castle Biosciences (CSTL) reported total debt of $36.72M in Q1 2026.
- How has Castle Biosciences's total debt changed year-over-year?
- Castle Biosciences's total debt increased by 42.1% year-over-year, from $25.84M to $36.72M.
- What is the long-term trend for Castle Biosciences's total debt?
- Over 4 years (2021 to 2025), Castle Biosciences's total debt has grown at a 45.3% compound annual growth rate (CAGR), from $8.31M to $37.02M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.